{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T16:44:53Z","timestamp":1793465093487,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001260","name":"National Organization for Rare Disorders","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001260","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["archives-pmr.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Physical Medicine and Rehabilitation"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.apmr.2025.10.013","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T15:59:18Z","timestamp":1762185558000},"page":"1480-1487","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Psychometric Properties of MFM32 in Myotonic Dystrophy Type 1"],"prefix":"10.1016","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-4955-1057","authenticated-orcid":false,"given":"Hanne Ludt","family":"Fossmo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Ellefsen-Martinsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"\u00d8rstavik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarun","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan C.","family":"Frich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilde Stendal","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apmr.2025.10.013_bib0001","doi-asserted-by":"crossref","DOI":"10.4045\/tidsskr.23.0687","article-title":"Myotonic dystrophy type 1 \u2013 a multiorgan disorder","volume":"144","author":"\u00d8rstavik","year":"2024","journal-title":"Tidsskr Nor Laegeforen"},{"key":"10.1016\/j.apmr.2025.10.013_bib0002","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1212\/CON.0000000000000793","article-title":"Myotonic muscular dystrophies","volume":"25","author":"Johnson","year":"2019","journal-title":"Continuum (Minneap Minn)"},{"key":"10.1016\/j.apmr.2025.10.013_bib0003","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1212\/CON.0000000000001184","article-title":"Myotonic dystrophy","volume":"28","author":"Hamel","year":"2022","journal-title":"Continuum (Minneap Minn)"},{"key":"10.1016\/j.apmr.2025.10.013_bib0004","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/ane.12565","article-title":"Major involvement of trunk muscles in myotonic dystrophy type 1","volume":"134","author":"Solbakken","year":"2016","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.apmr.2025.10.013_bib0005","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.nmd.2005.03.004","article-title":"A motor function measure for neuromuscular diseases. Construction and validation study","volume":"15","author":"B\u00e9rard","year":"2005","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.apmr.2025.10.013_bib0006","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s40120-020-00206-3","article-title":"Validity and reliability of the 32-item Motor Function Measure in 2- to 5-year-olds with neuromuscular disorders and 2- to 25-year-olds with spinal muscular atrophy","volume":"9","author":"Trundell","year":"2020","journal-title":"Neurol Ther"},{"key":"10.1016\/j.apmr.2025.10.013_bib0007","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0238786","article-title":"Assessment of the validity and reliability of the 32-item Motor Function Measure in individuals with type 2 or non-ambulant type 3 spinal muscular atrophy","volume":"15","author":"Trundell","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.apmr.2025.10.013_bib0008","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.apmr.2020.10.116","article-title":"Responsiveness and minimal clinically important difference of the motor function measure in collagen VI-related dystrophies and laminin alpha2-related muscular dystrophy","volume":"102","author":"Le Goff","year":"2021","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.apmr.2025.10.013_bib0009","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.nmd.2014.09.010","article-title":"Results of a two-year pilot study of clinical outcome measures in collagen VI- and laminin alpha2-related congenital muscular dystrophies","volume":"25","author":"Meilleur","year":"2015","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.apmr.2025.10.013_bib0010","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1016\/j.apmr.2014.06.005","article-title":"Rasch analysis of the motor function measure in patients with congenital muscle dystrophy and congenital myopathy","volume":"95","author":"Vuillerot","year":"2014","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.apmr.2025.10.013_bib0011","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1080\/17518423.2019.1642413","article-title":"Cross-cultural adaptation and multi-centric validation of the Motor Function Measure Chinese Version (MFM-32-CN) for patients with neuromuscular diseases","volume":"23","author":"Huang","year":"2020","journal-title":"Dev Neurorehabil"},{"key":"10.1016\/j.apmr.2025.10.013_bib0012","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1177\/0300060516674608","article-title":"Reliability of home-based, motor function measure in hereditary neuromuscular diseases","volume":"45","author":"Ruiz-Cortes","year":"2017","journal-title":"J Int Med Res"},{"key":"10.1016\/j.apmr.2025.10.013_bib0013","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.3906\/sag-1603-91","article-title":"Turkish version of the Motor Function Measure Scale (MFM-32) forneuromuscular diseases: a cross-cultural adaptation, reliability, and validity study","volume":"47","author":"\u0130nal","year":"2017","journal-title":"Turk J Med Sci"},{"key":"10.1016\/j.apmr.2025.10.013_bib0014","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1002\/acn3.51417","article-title":"Upper limb disease evolution in exon 53 skipping eligible patients with Duchenne muscular dystrophy","volume":"8","author":"Lilien","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.apmr.2025.10.013_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201004","article-title":"Prospective and longitudinal natural history study of patients with Type 2 and 3 spinal muscular atrophy: baseline data NatHis-SMA study","volume":"13","author":"Chabanon","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.apmr.2025.10.013_bib0016","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/MRR.0000000000000444","article-title":"Rasch analysis to evaluate the motor function measure for patients with facioscapulohumeral muscular dystrophy","volume":"44","author":"Mul","year":"2021","journal-title":"Int J Rehabil Res"},{"key":"10.1016\/j.apmr.2025.10.013_bib0017","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3233\/JND-230001","article-title":"Psychometric characteristics of the motor function measure in neuromuscular diseases: a systematic review1","volume":"10","author":"Ribault","year":"2023","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.apmr.2025.10.013_bib0018","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1212\/WNL.56.3.336","article-title":"Assessment of a disease-specific muscular impairment rating scale in myotonic dystrophy","volume":"56","author":"Mathieu","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.apmr.2025.10.013_bib0019","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.nmd.2007.02.013","article-title":"ACTIVLIM: a Rasch-built measure of activity limitations in children and adults with neuromuscular disorders","volume":"17","author":"Vandervelde","year":"2007","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.apmr.2025.10.013_bib0020","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1080\/09638288.2023.2231848","article-title":"Translation, reliability, and validity of the Norwegian version of the ABILHAND-NMD and the ACTIVLIM for Myotonic Dystrophy type 1","volume":"46","author":"Fossmo","year":"2024","journal-title":"Disabil Rehabil"},{"key":"10.1016\/j.apmr.2025.10.013_bib0021","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.nmd.2015.03.015","article-title":"Assessing upper extremity capacity as a potential indicator of needs related to household activities for rehabilitation services in people with myotonic dystrophy type 1","volume":"25","author":"Raymond","year":"2015","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.apmr.2025.10.013_bib0022","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s12891-015-0612-4","article-title":"Grip strength measured by high precision dynamometry in healthy subjects from 5 to 80 years","volume":"16","author":"Hogrel","year":"2015","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.apmr.2025.10.013_bib0023","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/acn3.496","article-title":"Relationships between grip strength, myotonia, and CTG expansion in myotonic dystrophy type 1","volume":"4","author":"Hogrel","year":"2017","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.apmr.2025.10.013_bib0024","series-title":"Measurement in Medicine","author":"de Vet","year":"2017"},{"key":"10.1016\/j.apmr.2025.10.013_bib0025","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","article-title":"A guideline of selecting and reporting intraclass correlation coefficients for reliability research","volume":"15","author":"Koo","year":"2016","journal-title":"J Chiropr Med"},{"key":"10.1016\/j.apmr.2025.10.013_bib0026","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.jclinepi.2005.10.015","article-title":"When to use agreement versus reliability measures","volume":"59","author":"de Vet","year":"2006","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.apmr.2025.10.013_bib0027","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41592-019-0470-3","article-title":"Moving beyond P values: data analysis with estimation graphics","volume":"16","author":"Ho","year":"2019","journal-title":"Nat Methods"},{"key":"10.1016\/j.apmr.2025.10.013_bib0028","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nmeth.3729","article-title":"Estimation statistics should replace significance testing","volume":"13","author":"Claridge-Chang","year":"2016","journal-title":"Nat Methods"},{"key":"10.1016\/j.apmr.2025.10.013_bib0029","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jclinepi.2006.03.012","article-title":"Quality criteria were proposed for measurement properties of health status questionnaires","volume":"60","author":"Terwee","year":"2007","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.apmr.2025.10.013_bib0030","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3389\/fncel.2015.00335","article-title":"The reliability of repeated TMS measures in older adults and in patients with subacute and chronic stroke","volume":"9","author":"Schambra","year":"2015","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.apmr.2025.10.013_bib0031","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/acn3.51281","article-title":"Natural history of Type 2 and 3 spinal muscular atrophy: 2-year NatHis-SMA study","volume":"8","author":"Annoussamy","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.apmr.2025.10.013_bib0032","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.nmd.2017.04.007","article-title":"A 9-year follow-up study of the natural progression of upper limb performance in myotonic dystrophy type 1: a similar decline for phenotypes but not for gender","volume":"27","author":"Raymond","year":"2017","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.apmr.2025.10.013_bib0033","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.3109\/09638288.2010.549287","article-title":"Functioning and disability in adults with myotonic dystrophy type 1","volume":"33","author":"Kierkegaard","year":"2011","journal-title":"Disabil Rehabil"}],"container-title":["Archives of Physical Medicine and Rehabilitation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003999325010044?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003999325010044?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T16:10:27Z","timestamp":1788538227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003999325010044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0003999325010044"],"URL":"https:\/\/doi.org\/10.1016\/j.apmr.2025.10.013","relation":{},"ISSN":["0003-9993"],"issn-type":[{"value":"0003-9993","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psychometric Properties of MFM32 in Myotonic Dystrophy Type 1","name":"articletitle","label":"Article Title"},{"value":"Archives of Physical Medicine and Rehabilitation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apmr.2025.10.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by the American Congress of Rehabilitation Medicine. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}